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Abstract 
The conformation of the anti-cancer drug daunomycin 
has been investigated in detail by potential-energy 
calculations. The flexibility around the ether linkage, 
connecting the anthracycline chromophore and the 
amino sugar group, has been evaluated using several 
types of potential-energy function. The results largely 
support the hypothesis that the crystallographically 
observed conformation is the most stable one, although 
considerable detailed variation with respect o potential 
function was found. 
Introduction 
We have previously reported (Neidle & Taylor, 1979) 
the results of a conformational analysis on the 
antileukaemic antibiotic daunomycin (Fig. 1), using 
empirical force-field methods of calculating non-bonded 
energies. These results indicated that the minimum- 
energy conformation corresponds to that observed in 
the crystal structures of daunomycin itself [as a 
pyridine adduct (Neidle & Taylor, 1977) and a butanol 
* To whom correspondence should be addressed. 
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Fig. 1. Molecular structure of daunomycin (R = H). Adriamycin 
has R = OH. Torsion angles ~0 t and ~0 2 are defined by C(8) -  
C(7) -O(7) -C( I ) '  and C(7) -O(7) -C(1) ' -O(5) '  respectively. 
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adduct (Courseille, Busetta, Geoffre & Hospital, 
1979)], of N-bromoacetyldaunomycin (A giuli et al., 
1971), and of 4-hydroxydaunomycin (carminomycin) 
(Wani, Taylor, Wall, McPhail & Onan, 1975; Pettit et 
al., 1975; Von Dreele & Einck, 1977). The confor- 
mational analysis was performed by examining the 
relative dispositions of the sugar group and anthra- 
cycline chromophore, by varying the two bond torsion 
angles tp~ and ~2 and maintaining the rest of the 
molecular structure in the crystal geometry (Neidle & 
Taylor, 1977). 
A recent analysis of the closely related antibiotic 
adriamycin (also termed doxorubicin) has cast some 
doubt on these findings with the location of a distinct 
global minimum-energy conformation (Nakata & 
Hopfinger, 1980). This, it is suggested, is stabilized by 
an intramolecular hydrogen bond between H(6) and 
0(5)' (Fig. 1). 
In an effort to resolve this conflict, we have 
systematically analysed the conformational and 
hydrogen-bonding energies, using a number of distinct 
approaches. We find that precise calculated confor- 
mations and their relative associated energies depend to 
a considerable xtent on the particular energy formal- 
ism employed. However, in no case can we reduce the 
minimum-energy region found (Nakata & Hopfinger, 
1980) to a global minimum stabilized by an intra- 
molecular hydrogen bond between H(6) and 0(5)' 
(Fig. 1), since this would require the breaking of 
an already existing strong hydrogen bond 
[O(5)...H(6)-O(6)]. Throughout our calculations we 
have employed fixed bond distance and angle geom- 
etry, since the several precise crystallographic studies 
indicate that the bonding geometry does not vary in 
diverse crystallographic environments. In contrast, 
Nakata & Hopfinger (1980) have optimized a doxo- 
rubicin geometry which was derived from N-bromo- 
acetyldaunomycin (Angiuli et al., 1971) although the 
final geometry that they obtained has not been stated. 
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We have deliberately used various types of com- 
monly used functions and associated constants, o as to 
represent a broad spectrum of analysis. 
A recent complete optimization of daunomycin is in 
substantial agreement with our results (Brown, 
Kollman & Weiner, 1982). 
Methods 
The semi-empirical energy of a particular conformation 
was calculated as the sum of terms representing 
non-bonded (N-B), torsional (TORS), electrostatic 
(E-S) and hydrogen-bonding potential energies (H-B): 
VTo  = + V o.s + VE_s + vH_, 
where 
V~ 
VTORS = ~ (1 + cos n~0) 
2 - 
q lq2  
VE-S-- 
er 
-A  B 
VN-B-  r6 + rl 2 
--A 
or -- + B exp Cr 
r 6 
VH-B -- - -  
AH B H 
r12 rio 
Table 1 details values used for the constants in these 
experiments. A value of unity for the dielectric onstant 
(e) was employed for the results presented here. 
Generally, although the total electrostatic contribution 
was reduced on using a distance-dependent function for 
e (Table 1), no significant differences were obtained 
either in the positions of the minima in the maps or in 
their general shape. Since we were only interested in the 
relative energies of the molecule with respect to the 
crystal conformation, e = 1 was chosen for 
convenience. 
Individual atomic partial charges were taken from 
the study of Nakata & Hopfinger (1980), and were also 
calculated for specific fragments of the daunomycin 
molecule using the GA USSIAN 76 ab initio quantum- 
chemistry programs (Pople, Binkley, Whiteside, 
Hariharar & Seeger, 1978) (Table 2). When studying 
hydrogen bonding the minimal STO-3G base was used, 
and the bond lengths and angles were constrained to 
their crystal values. Fragmentation of a molecule of the 
size of daunomycin is essential because of the severe 
limitation in the number of atomic nuclei that can be 
currently simultaneously considered in the ab initio 
approach, on the computer systems available to us. It is 
well known that results obtained by these methods 
show dependence on the nature of the base set used. 
Since, however, the overall energy of a hydrogen bond 
has been found (Iwata & Morokuma, 1973) to be lower 
for the STO-3G base set than for more extended ones, 
it is felt that the minimal set was adequate for the 
present purpose, to give an upper limit to the 
hydrogen-bond energy and for comparison with the 
empirical energy calculated. The ab initio method was 
also employed to calculate the total potential energy of 
a particular conformation of the daunomycin fragment. 
The fragment considered (Fig. 2) was taken by us to be 
a representative model for the intramolecular hydrogen 
bonding in daunomycin and anthraquinones. 
Ab initio calculations were performed on the 
University of London CDC 7600 computer. Confor- 
mational energies and flexibilities were calculated on a 
Table 1. Definition of parameters and atom types used 
in non-bonded potentials 
(a) Parameters for 6-12 potential 
Parameter set A 
a: polarizability (x 1024 cm ~) 
N: effective numbers of electrons 
R: van der Waals radii (A) 
Type Species t~ N R 
1 H 0.42 0.85 1.20 
2 C (sp 2) 1.30 5.2 1.70 
3 C (sp a) 5.2 1.70 1.70 
4 CH (aliphatic) 1.35 6.0 1.95 
5 CH 2 (aliphatic) 1.77 7.0 1.95 
6 CH 3 (aliphatic) 2.17 8.0 1.95 
7 CH (aromatic) 2.07 6.0 1.90 
8 N (sp2-amide) 1.15 6.0 1.55 
9 N (sp a) 0.87 6.0 1.55 
10 N (sp 3) 0.87 9.0 1.75 
11 N ÷ (imidazole) 2.03 6-0 1.65 
12 0 (sp) 0.85 7.0 1.52 
13 O (sp 2) 0.59 7.0 1.52 
14 O- (carboxyl) 2.14 7.0 1.60 
15 S (single bonds) 0.34 16.0 i.80 
16 S (single bonds) 0.50 14.8 1.80 
17 P 3.45 14.2 1.80 
Working 6-12 formula 
3 eh 
V - .A. {[1.0 - (R6/D6)I /D6} 
A = cq. a2 / [ (a l /NO 1/2 + (cq/N2)l/2l 
R = R I + R 2 
References 
Atom type Variable Reference 
3-9 a Olson (1973) 
16 ct Lindeberg & W~igner (1977) 
17 a Thornton & Bayley (1975) 
14 a = 1.47 
All other a's from Gibson & Scheraga (1967) 
All N's from Scott & Scheraga (1965) 
All R's from Bondi (1964) 
Parameter set B 
Parameters taken from Stuper, Dyott & Zander (1979) 
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Table 1 (cont.) 
(b) Parameters for 6-exp potential 
A B 
Atom pair (kJ mol -~ A 6) (kJ mol -~) 
H-H 79.72 6876.0 
H-C 504.08 47278.0 
H-O 504.08 47278.0 
H-N 504.08 47278.0 
H-P 1604.53 14505.2 
C-C 3125.36 386820.0 
C-N 3125.36 386820.0 
C-O 3125.36 205186.4 
C-P 10044.00 1277969.3 
N-N 3125.36 386820.0 
N-O 3125.36 205186.4 
N-P 10044.00 1277969.3 
O-O 3125.36 176422.9 
O-P 10044.00 1074599.2 
Working formula 
V = -A(D -6) + B exp [-(CD)I 
Nuss, Marsh & Kollman (1979) 
Parameters for torsion potential 
v0 
Group (kJ mol- i) 
-C -O 4.2 
Hopfinger (1973) 
(c) Parameters for hydrogen bonding 
Sign N 
+ 3 
An Bn Rmln(O-O) eml n 
(kJ mo1-1/k 12) (kJ mol -l/k l°) --(,~,) (kJ mol -~) 
50387 16799 1.9 -4.65 
55845 24202 1.66 -24.78 
54543 19293 1.84 - 7.41 
Scheraga (1974) 
Umi n is the minimum energy for the hydrogen bond defined by the 
minimum Rmin(O-O ) distance. 
Dielectric onstant 
e = 1 and also simple distance-dependent li ear functions were tried 
(see Hopfinger, 1973); these are of the form: 
e= l for rij < 3 A 
e = 0-75. r l j -  1.25 for 3/k < rij < 7 
e=4forr~j> 7A. 
All maps shown are for e = 1. 
PDP 11/34 computer with an interactive graphics 
facility. 
Table 2. Ind iv idual  atomic part ia l  charges 
(a) Results of partial-charge calculations using GA USS1AN 76, at 
various r2 values, for several atom species of the carminomycin C (A- i) fragment in Fig. 2. 
3.76 0(5)...H(6) 
3.67 r2 (o) distance (A) H(6) 0(6) 0(5) C(6) 
3.60 
5 3.60 0.183 -0.244 -0.186 0- 143 3.60 
50 3.32 0.178 -0.255 -0.182 0.134 3.60 
90 2.77 0.175 -0.263 -0.185 0-127 3.60 
120 2.26 0.188 -0.263 -0.201 0.133 3.60 
140 1.94 0.208 -0.272 -0-218 0.140 3.60 
154 1.76 0.226 -0-286 -0.232 0.146 3.60 164 1.67 0.238 -0.297 -0.240 0-150 3.60 
170 1-67 0.240 -0.301 -0.242 0.151 3.60 
180 1.63 0.244 -0.304 -0.244 0-152 3.60 
200 1.73 0.230 -0.289 -0.235 0.147 3.60 
3.60 
(b) Results of Nakata & Hopfinger (1980) 
r 2 (°) H(6) 0(6) 0(5) C(6) 
53 0.150 -0.265 -0.250 0.175 
Results and discussion 
Calculations, using the Nakata  & Hopfinger (1980) 
partial charges (obtained by CNDO/2  methods), were 
performed on all the daunomycin analogues examined 
crystallographically. Our own partial-charge cal- 
culations on carminomycin fragments gave very similar 
results to these, apart from differences in the region of 
the hydroxyl  protons, which are particularly important 
for hydrogen-bond potentials. Since the model used by 
Nakata  & Hopfinger for hydrogen bonding is an 
o H~ 0 
65 H~O,6 
Fig. 2. Fragment used to model hydrogen bonding for ab initio 
calculation. The torsion angle r 2 is defined by the atom sequence 
C (6A)-C (6)-0 (6)- H (6). 
electrostatic one, use of different partial charges would 
have made a significant difference to their results. In 
order to preserve standardization as far as possible with 
their results the Nakata & Hopfinger partial charges 
were used, except when we specifically considered 
hydrogen bonding. For any one type of calculation, the 
results were broadly similar for all derivatives. We have 
concentrated on discussing those for carminomycin 
since its crystal lographic analysis is the most accurate 
of the series, with H-atom positions being located and 
hence hydrogen-bonding geometry being determined. 
By contrast, the crystal lographic analysis of N-bromo- 
acetyldaunomycin (Angiuli et al., 1971), which was 
used as the basis of the calculations on adriamycin 
(Nakata & Hopfinger, 1980), is of an order of 
magnitude less in precision, and therefore far less 
reliable. 
Figs. 3-6 and Table 3 show the results of calcu- 
lations on carminomycin using differing potential 
terms. In general, hydrogen-bond energies have been 
excluded from these scans. All three conformational 
maps show the same relatively broad minimum at ¢p~ _~ 
90 °, (o 2 _~ 290 ° , which is the area of the crystal- 
lographically observed conformations, as well as being 
in agreement with our earlier results (Neidle & Taylor, 
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100 
3 
300, 
1 O0 200 300 ~, 
Fig. 3. Conformational map l using the 6-12 potential function and 
parameter set B (Table 1)1 for carminomycin. Angles ¢~ and ~2 
are defined in Fig. 1. The r~ angle is at its crystallographic 
position of 18 o. 
(~ 3 
100 200 300 (I), 
Fig. 4. Conformational map (using the 6-12 potential function and 
parameter set B), with r = 180 °. 
~ 10 
100 200 300 m, 
Fig. 5. Conformational map [using the 6-12 potential function and 
parameter set A (Table 1)1 for carminomycin. 
~2 
300 
200 
100 200 300 ~, 
Fig. 6. Conformational map (using the 6-exp potential function) for 
carminomycin. 
1979). However, other features of the maps are 
significantly distinct from one to the other. The 
subsidiary minimum at ~p~ ~_ 90 °, tp2 ~_ 200 ° has a 
barrier of ~ 12.6 kJ mo1-1 between it and the global 
minimum, in Fig. 3. In contrast, the other maps with 
different erms (Figs. 5 and 6), show a much broader 
global minimum, with the subsidiary one at most about 
4.2 kJ mo1-1 above it. The minimum at ~0, ~ 240% tp2 ~_ 
250 o, is in the region of the Nakata & Hopfinger global 
minimum. 
The barrier at the (257 °, 257 °) position (Nakata & 
Hopfinger, 1980) arises from close contacts developing 
between the daunosamine sugar atoms HC(1)', C(1)' 
and C(2)' and the 0(9) hydroxyl group (Fig. 1). Hence 
the relative height of this barrier is highly dependent 
upon the disposition of the C(9) hydroxyl group. 
(~0,tp2) conformation scans were carried out as a 
function of the C(8) -C(9) -O(9) -H(9)  torsion angle 
(rl) at a number of discrete r~ values distinct from the 
crystallographic position of q = 18 °. The 0(9) -  
H(9). . .O(7) interaction was included in these cal- 
culations. Again the results were highly dependent 
upon the form of the potential function used. The 
energy of the hydrogen bond was obtained using the 
expression VH_ B given above. The results overall 
indicated a retention of the features of the (~0~,~02) scan 
when q was in the crystallographically observed 
position, in that the global minimum is always at the 
(~0~,~02) crystallographic position regardless of the 
Table 3. Features of the conformational maps 
Compound 
Carminomycin 
N-Bromoacetyldaunomycin 
Relative nergy at 
90 ° , 290 ° 
Position of (crystallographic Relative nergy at 
Non-bonded principal minimum minimum) in (260 ° , 260 ° ) in 
function used ~0~, ~P2 (o) kJ mol -~ kJ moi -~ 
'6-12' parameter 100, 290 0 >84 
set A (Fig. 5) 
'6-12' parameter 100, 300 0 12.6 
set B (Fig. 4) 
'6-exp' (Fig. 6) 100, 280 0 50.4 
'6-12' parameter 100, 200 <2.1 16.8 
set B, with r = 53 o 
'6-12' parameter 90, 200 4.2 25- 2 
set A 
'6-12' parameter 90, 290 0 12.6 
set B 
'6-exp' 80, 220 8.4 16.8 
Other minima (°) 
and their relative 
energies 
kJ mol -~ 
100°,180°; 
4.2 
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Table 4. The effect of variation in the r I torsion angle 
on the energy of the minimum positions in the ~o~,~2 
maps 
In all cases, the minimum was at ~o~  100% ~o 2~ 290 °. The '6-12' 
parameter set B was used for these calculations. 
Relative nergy 
rl (o) (kJ mo1-1) 
18 12.6 
30 4.2 
90 5.5 
120 12.6 
180 6.3 
values of r I (Table 4). However, the energy at the 
position of the Nakata & Hopfinger minimum is 
reduced from 12.6 at r~ = 18 o to ~ 6.3 kJ mol -~ (at r l 
= 180 °, the Nakata & Hopfinger position) above the 
global minimum in Fig. 3. For the conditions used in 
Fig. 4, the barrier height at this minimum is reduced to 
~42 kJ mol -~ above the global minimum for r I = 
180 ° . 
These results reinforce our view that starting with the 
observed carminomycin crystal conformation is the 
most valid approach. It is apparent that in no instance 
is this position less than 12.6 kJ mol -~ above the global 
minimum in energy, leading one to conclude that this 
minimum is not a global one, as judged by the various 
distinct calculations we have used. Moreover, this 
minimum varies significantly in energy, with a dif- 
ference of 42 kJ mol -~ between Figs. 5 and 6. We are 
unable to judge which, if any, more nearly represent 
reality. This wide variation does, however, suggest that 
the quantitative results from any one empirical force- 
field calculation, at least on molecules of the present 
type, must be treated and used with some caution. 
Energy calculations have also been performed with 
the O(6)-H(6) bond in the Nakata & Hopfinger 
position, with r2 = 53 ° (Table 3). Again, the 
minimum-energy position is at (90 °, 290°), with an 
energy barely distinguished from that in the other 
carminomycin calculations. 
An identical set of calculations has also been 
performed on the considerably less reliable molecular 
geometry of N-bromoacetyldaunomycin. Table 3 gives 
the results of these. In all three cases, the (257 o, 257 o) 
minimum is still above the global one, though now the 
former is only 12.6-25.2 kJ mol -~ greater in energy. 
Considerable differences between three conformational 
maps are observed in the region of the global minimum, 
which is actually shifted to (90 °, 200°), although this 
is only about 8.4 kJ mol -~ below the energy at the 
(90 ° , 290 ° ) position. We conclude that these calcu- 
lations again broadly demonstrate a correspondence 
between the crystallographic and calculated minimum 
conformation, with the important proviso of inaccuracy 
in the starting-point geometry in this instance. 
An important feature of the Nakata & Hopfinger 
global minimum molecular geometry, as compared to 
the crystallographic one, concerns its hydrogen bond- 
ing. In the former, it is stated that stabilization of this 
conformation is produced by an intramolecular hydro- 
gen bond between the hydroxyl group at 0(6) on the 
chromophore, and the sugar ring O atom 0(5)'. We 
first note that this arrangement has not been observed 
experimentally in any of the crystal structures; in that 
of carminomycin (Von Dreele & Einck, 1977), where 
H-atom positions were observed, one intramolecular 
hydrogen bond is unequivocally between 0(7) and 
O(9), with standard hydrogen-bonding geometry being 
observed [the O(7) . . .H(9) -O(9)  angle is, for ex- 
ample, 141 o ]. Other intramolecular hydrogen bonding 
involves (a) carbonyl 0(5) and phenolic H(6) and (b) 
carbonyl O(12) and phenolic H(11). Recent NMR data 
in solution fully support these assignments (Patel, 
Kozlowski & Rice, 1981). The alternative arrangement 
proposed (Nakata & Hopfinger, 1980) has an 0 (6) -  
H(6). . .O(5) '  angle of about 120°. We consider this 
arrangement less plausible in the light of the accepted 
geometry of hydrogen bonding (Donohue, 1968). 
Furthermore, we have carried out extensive calcu- 
lations on the various hydrogen-bonding possibilities 
(to be reported in detail elsewhere), which have further 
supported our rejection of the O(6) -H(6) . . .O(7)  
hydrogen bond. The results of ab initio calculations on 
the variation of energy with rotation of the H(6) atom 
around the C(6)-O(6) bond are shown in Figs. 7 and 
8. These results reveal the presence of a pronounced 
energy minimum at the point of closest approach to the 
carbonyl atom 0(5). It is reasonable to interpret his 
as corresponding to an O(6) -H(6) . . .O(5)  intra- 
molecular hydrogen bond, which is indeed observable 
~" 50 
40 
to 
30 
20 
10 
0 
-10 
-20 
-312 
1.09 
o 
Fig. 7. Change in energy of fragment (Fig. 2) as a function of the 
torsion angle C(6A)-C(6)-O(6)-H(6) (r2) (Fig. 2) using 
GA USSIAN 76. The energy at the crystal conformation has been 
set to zero. The change in energy shown both here and in Fig. 8. 
is the total of torsion and hydrogen-bond energy, and is not to be 
taken as representing only the latter. 
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~ 50 ~ -~1.09  
40 
20. = 0.95 
10 
0 / /2.0 2.5 3.0 3.5 
-10 ~ / R(O...H)(A) 
-20 
-30 
Fig. 8. Change in energy of the fragment (Fig. 2) as a function of 
the H(6)...O(5) distance (Fig. 2) calculated using GA USSIAN 
76. The energy at the crystal conformation has been set to zero. 
in the crystal. The conformation of the O(6)-H(6) 
bond which could give rise to an O(6)-H(6) . . .O(5) '  
hydrogen bond has r 2 = 53 o which is over 42 kJ mo1-1 
less favoured than the strong O(6)-H(6) . . .O(5)  one. 
This destabilization at r2 = 53 ° has not been included 
in the calculation of the energies given in Table 3; its 
conclusion would tend to make the Nakata & 
Hopfinger minima of higher energy. Figs. 7 and 8 show 
the same general features for the O(6)-H(6) distance 
of 0.95 A, compared to the perhaps more likely one of 
1.09 A. This difference in hydrogen-bond strengths, 
coupled with the lack of a global minimum in the region 
of the (260 °, 260 °) conformation (Table 3), further 
argues against he likelihood of this alternative being 
the stable form of the molecule. 
Conclusions 
It is apparent hat for three different, commonly used 
empirical force-field energy-calculations methods, the 
minimum conformation found is close to that seen in 
the crystalline state in a variety of environments. This 
conformation has also now been observed when 
adriamycin is bound to a hexanucleotide system 
modelling DNA itself (Quigley, Wang, Ughetto, van 
der Marel, van Boom & Rich, 1980). It is further clear 
that quantitative interpretations of such calculations 
are not straightforward, and are markedly dependent 
on the formalism employed. 
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